These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


222 related items for PubMed ID: 4284276

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Absence of favorable effects of pressor agents on cardiac output and peripheral circulatory flow in advanced shock].
    Faucon G, Evreux JC, Lavarenne J, Collard M, Perrot E.
    Pathol Biol; 1968 Jan; 16(1):5-15. PubMed ID: 4296600
    [No Abstract] [Full Text] [Related]

  • 23. Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial.
    Wieruszewski PM, Bellomo R, Busse LW, Ham KR, Zarbock A, Khanna AK, Deane AM, Ostermann M, Wunderink RG, Boldt DW, Kroll S, Greenfeld CR, Hodges T, Chow JH, Angiotensin II for the Treatment of High-Output Shock 3 (ATHOS-3) Investigators.
    Crit Care; 2023 May 05; 27(1):175. PubMed ID: 37147690
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Indications, in anesthesia-resuscitation, for various analeptics during obstetrical shock].
    Mai van Dau C.
    Anesth Analg (Paris); 1969 May 05; 26(5):743-8. PubMed ID: 4312808
    [No Abstract] [Full Text] [Related]

  • 27. Current status of the treatment of shock complicating acute myocardial infarction.
    Friedberg CK.
    J Trauma; 1969 Feb 05; 9(2):141-2. PubMed ID: 5763330
    [No Abstract] [Full Text] [Related]

  • 28. Hemodynamic spectrum of vasopressor and vasodilator drugs.
    Lewis CM, Weil MH.
    JAMA; 1969 May 26; 208(8):1391-8. PubMed ID: 4307223
    [No Abstract] [Full Text] [Related]

  • 29. [Shock therapy with vasodilator and-or vasoconstrictor agents].
    Wolff G, Gigon JP, Enderlin F.
    Helv Chir Acta; 1967 Feb 26; 34(1):26-31. PubMed ID: 4295568
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. THE MECHANISM OF SHOCK FOLLOWING SUICIDAL DOSES OF BARBITURATES, NARCOTICS AND TRANQUILIZER DRUGS, WITH OBSERVATIONS ON THE EFFECTS OF TREATMENT.
    SHUBIN H, WEIL MH.
    Am J Med; 1965 Jun 26; 38():853-63. PubMed ID: 14310001
    [No Abstract] [Full Text] [Related]

  • 34. Angiotensin II: a new approach for refractory shock management?
    Kimmoun A, Levy B.
    Crit Care; 2014 Dec 18; 18(6):694. PubMed ID: 25645552
    [Abstract] [Full Text] [Related]

  • 35. Intravenous dopamine in the treatment of myocardial dysfunction after open-heart surgery.
    Rosenblum R, Frieden J.
    Am Heart J; 1972 Jun 18; 83(6):743-8. PubMed ID: 5053143
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.